Cancer cells adapt to hypoxia by modulating the expression of genes involved in neoangiogenesis (e.g., vascular endothelial growth factor, VEGF), glucose uptake (e.g., glucose transporter, GLUT1), pH modulation (e.g., carbonic anhydrase IX, CA9), and other adaptive mechanisms. Here, CA9 is linked to cancer.